FIERCEPHARMA AND FIERCEBIOTECH PRESENT:

Medical Affairs Strategic Summit East

NOW AVAILABLE ON-DEMAND

 

WATCH NOW Group

Medical affairs plays a pivotal role in communicating with external experts and clinicians, and is key to identifying unmet medical needs, raising awareness with clinicians, and providing valuable feedback and insights that can better inform an organization’s development strategy. After years of proven success, the Medical Affairs Strategic Summit (MASS) East returns in a virtual setting to serve as an educational platform to provide a holistic view of medical affairs, allowing your organization to develop a unified scientific voice and ultimately help position your team as a strategic and credible customer-facing partner in today’s healthcare landscape.

*Please note registration is complimentary for professionals from pharmaceutical, biotech, and medical device organizations. To register, please fill out the registration form. Once submitted, someone from our team will review your registration and approve it accordingly. Please note that you will not have immediate access to the virtual event. Once approved, you will receive an email with your login information.

FIVE FOCUS AREAS FOR 2020

Launch readiness
Medical affairs strategy
Medical operations
MSL
IIT
June 1

MONDAY, JUNE 1
LAUNCH READINESS

 

10:15AM ET

Panel Discussion: Explore Launch Planning for Organizations of Varying Sizes

 

11:10AM ET

Leverage Online Discussion Platforms for Optimal Stakeholder Engagement

 

12:00PM ET

Panel Discussion: Streamline Efficiencies and Improve Techniques to Build and Run Advisory Boards

 

12:55PM ET

Panel Discussion: How Field Medical Can Help Prepare the Market for a New Drug Launch

June 2

TUESDAY, JUNE 2
MEDICAL AFFAIRS STRATEGY

 

10:15AM ET

The Evolution of Medical Affairs: Playing a Leading Role in the Product Lifecycle Within the Healthcare Ecosystem

 

11:10AM ET

Integrate HEOR into the Medical Affairs Product Strategy

 

12:00PM ET

Panel Discussion: Discuss the Benefits of Engagement from the Medical Affairs Team Early in the Product Lifecycle

June 3

WEDNESDAY, JUNE 3
MEDICAL OPERATIONS & TECHNOLOGY

 

10:15AM ET

Determine next steps following the development of your medical strategy

 

10:55AM ET

Improving Lives by Harnessing the Power of Patient Journey Complete Encounters

 

11:45AM ET

Leveraging Technology to Standardize Medical Grants Programs and Digital Outcomes

 

12:25PM ET

Review the Impact of Real-World Evidence on Medical Affairs Strategy

june 4

THURSDAY, JUNE 4
MSL & FIELD STRATEGY

 

10:15AM ET

The Ever-Elusive Balance of Quantity vs. Quality in MSL Goals and Metrics

 

10:55AM ET

Panel Discussion: Build the MSL Career Path with a Focus on Facilitating Team Retention

 

12:00PM ET

Panel Discussion: Dissemination of Off Label Information in a Compliant Manner

JUNE 5

FRIDAY, JUNE 5
INVESTIGATOR-INITIATED TRIALS

 

10:15AM ET

Panel Discussion: Share Best Execution Practices for IITs in Different Therapeutic Areas

 

11:10AM ET

Effectively Demonstrate the Value of Investigator-Sponsored Research to Internal Leadership

 

12:00PM ET

Establish an Efficient and Compliant Process for Assessing the Fair Market Value (FMV) of IIT Budgets

 

12:40PM ET

Deep Dive into Best Practices for Negotiating Contracts to Improve Study Start-Up

WATCH ON-DEMAND NOW! Group

EVENT HIGHLIGHTS
 

  • Discover how innovative technologies like artificial intelligence and real-world evidence platforms can impact medical affairs operations
  • Streamline efficiencies and improve techniques to build and run advisory boards, engage with KOLs, and collect and leverage insights to drive value for external stakeholders

  • Look at data mining activities that enhance customer engagement, and the new and improved ways to effectively collect and synthesize MSL insights

  • Look into medical strategy improvements from early engagement in the product lifecycle to product launch effortstherapies

  • Explore approaches to improve internal approval processes for new investigator-initiated studies, determine fair market value, and manage the study life cycle while staying compliant with current regulations

 

Who Should Attend:

This conference is designed for representatives from pharmaceutical, biotechnology, and medical device organizations with responsibilities in the following areas:

  • Medical Affairs/Field Medical Affairs
  • Clinical/Scientific Affairs
  • Medical Science Liaisons/MSLs
  • Medical Strategy/Communications
  • Medical/Clinical Operations
  • KOL/Thought Leader Relations/Engagement
  • Investigator-Initiated Research (IIR)
  • Investigator-Initiated Studies (IIS)
  • Investigator-Initiated Trials (IIT)
  • Investigator-Sponsored Trials (IST)
  • Research Collaborations
  • Medical/Scientific/Patient Communications
  • Medical Information
  • Medical Education
  • Publication Planning
  • Health Economics and Outcomes Research/HEOR
  • Compliance/Legal
  • Regulatory Affairs
  • Research Grants
  • Call Center Management
  • Patient Services
  • Clinical Outcomes and Publications

2020 Sponsors

Strategic Partners

Sponsors